Clincosm LogoSign in Get a demo

Waldenstrom Macroglobulinemia

Showing NaN - NaN of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • B-Cell Lymphoproliferative Disorder
  • Boston, Massachusetts
  • +2 more
Feb 18, 2023

IgM MGUS, Waldenstrom Macroglobulinemia, Neuropathy;Peripheral Trial in Boston (Acalabrutinib, Rituximab)

Recruiting
  • IgM MGUS
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 14, 2022

Waldenstrom Macroglobulinemia Trial in United States (Umbralisib)

Completed
  • Waldenstrom Macroglobulinemia
  • Washington, District of Columbia
  • +3 more
Oct 19, 2022

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Lymphocytic, Small, Lymphoma, Mantle-Cell Trial in Worldwide (Pirtobrutinib)

Available
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +4 more
  • Stanford, California
  • +61 more
Aug 17, 2022

MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular

Recruiting
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • +8 more
    • Boston, Massachusetts
    • +6 more
    Apr 14, 2022

    Waldenstrom Macroglobulinemia, MYD88 Gene Mutation Trial in Boston (IBRUTINIB, Venetoclax)

    Active, not recruiting
    • Waldenstrom Macroglobulinemia
    • MYD88 Gene Mutation
    • Boston, Massachusetts
    • +1 more
    Apr 1, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)

    Enrolling by invitation
    • Chronic Lymphocytic Leukemia
    • +6 more
    • Duarte, California
    • +165 more
    Mar 24, 2022

    Waldenstrom Macroglobulinemia, DASATINIB Trial in Boston (Dasatinib)

    Recruiting
    • Waldenstrom Macroglobulinemia
    • DASATINIB
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Mar 22, 2022

    Waldenstrom Macroglobulinemia Trial in Boston (Loncastuximab Tesirine, Dexamethasone)

    Recruiting
    • Waldenstrom Macroglobulinemia
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Mar 1, 2022

    Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in United States (oprozomib)

    Terminated
    • Multiple Myeloma
    • Waldenstrom Macroglobulinemia
    • Scottsdale, Arizona
    • +18 more
    Nov 15, 2021

    Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

    Terminated
    Has Results
    • Adult Grade III Lymphomatoid Granulomatosis
    • +116 more
    • brentuximab vedotin
    • +2 more
    • Chicago, Illinois
    • +2 more
    Aug 30, 2021

    Waldenström Macroglobulinemia Trial in United States (Zanubrutinib)

    No longer available
    • Waldenström Macroglobulinemia
    • Mobile, Alabama
    • +19 more
    Jun 8, 2021

    Covid-19 Vaccine Responsiveness in MM and Waldenstrom

    Not yet recruiting
    • Multiple Myeloma
    • +3 more
      • Boston, Massachusetts
      • +1 more
      Mar 31, 2021

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Lymphoplasmacytoid Lymphoma Trial in United States (SNS-062)

      Terminated
      • Chronic Lymphocytic Leukemia
      • +7 more
      • Orange, California
      • +10 more
      Oct 15, 2020

      B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

      Completed
      Has Results
      • B-cell Chronic Lymphocytic Leukemia
      • +9 more
      • Stanford, California
      • +15 more
      May 14, 2020

      B Cell Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia Trial in United States (AVL-292)

      Completed
      • B Cell Non-Hodgkin's Lymphoma
      • +2 more
      • Huntsville, Alabama
      • +12 more
      Nov 6, 2019

      Contiguous Stage II Adult Diffuse Large Cell Lymphoma, MALT, Nodal Marginal Zone B-cell Lymphoma Trial in Boston (biological,

      Terminated
      Has Results
      • Contiguous Stage II Adult Diffuse Large Cell Lymphoma
      • +7 more
      • rituximab
      • +7 more
      • Boston, Massachusetts
        Eastern Cooperative Oncology Group
      Apr 20, 2017

      Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient

      Completed
      • Accelerated Phase Chronic Myelogenous Leukemia
      • +50 more
      • Akt inhibitor MK2206
      • +2 more
      • Birmingham, Alabama
      • +24 more
      Apr 28, 2014

      Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic

      Completed
      • Accelerated Phase Chronic Myelogenous Leukemia
      • +84 more
      • sunitinib malate
      • +2 more
      • Los Angeles, California
      • +10 more
      Mar 14, 2014

      Relapsed Multiple Myeloma, Refractory Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in United States (MLN0128)

      Completed
      • Relapsed Multiple Myeloma
      • +2 more
      • San Francisco, California
      • +5 more
      Jul 31, 2013